The invention relates to an improved process for the manufacture of bis-resorcinyl triazines of formula (I) wherein R.sup.1 is a C.sub.1C.sub.18alkyl group or C.sub.2-C.sub.18alkenyl group as well as the respective alkyl substituted bis-resorcinyl derivatives of formula (II) wherein R.sup.1 is a C.sub.1-C.sub.18alkyl group or C.sub.2-C.sub.18alkenyl group and R.sup.2 and R.sup.3 are independently of each other a C.sub.1-C.sub.18alkyl group or a C.sub.2-C.sub.18alkenyl group. ##STR00001##

The invention relates to an improved process for the manufacture of bis-resorcinyl triazines of formula (I) wherein R.sup.1 is a C.sub.1C.sub.18alkyl group or C.sub.2-C.sub.18alkenyl group as well as the respective alkyl substituted bis-resorcinyl derivatives of formula (II) wherein R.sup.1 is a C.sub.1-C.sub.18alkyl group or C.sub.2-C.sub.18alkenyl group and R.sup.2 and R.sup.3 are independently of each other a C.sub.1-C.sub.18alkyl group or a C.sub.2-C.sub.18alkenyl group. ##STR00001##

Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.

The invention relates to compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing said compounds.

The invention relates to compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing said compounds.

The present invention relates to a class of compounds represented by the formula I, or pharmaceutically acceptable salts thereof, methods for their preparation, and application as small molecule tools that function as GPR84 agonists, and their use in preparing a medicament for the treatment of septicemia.

##STR00001##

The invention relates to an improved process for the manufacture of bis-resorcinyl triazines of formula (I) wherein R.sup.1 is a C.sub.1C.sub.18alkyl group or C.sub.2-C.sub.18alkenyl group as well as the respective alkyl substituted bis-resorcinyl derivatives of formula (II) wherein R.sup.1 is a C.sub.1-C.sub.18alkyl group or C.sub.2-C.sub.18alkenyl group and R.sup.2 and R.sup.3 are independently of each other a C.sub.1-C.sub.18alkyl group or a C.sub.2-C.sub.18alkenyl group.

##STR00001##

The invention relates to an improved process for the manufacture of bis-resorcinyl triazines of formula (I) wherein R.sup.1 is a C.sub.1C.sub.18alkyl group or C.sub.2-C.sub.18alkenyl group as well as the respective alkyl substituted bis-resorcinyl derivatives of formula (II) wherein R.sup.1 is a C.sub.1-C.sub.18alkyl group or C.sub.2-C.sub.18alkenyl group and R.sup.2 and R.sup.3 are independently of each other a C.sub.1-C.sub.18alkyl group or a C.sub.2-C.sub.18alkenyl group.

##STR00001##

The present disclosure pertains to antimicrobial compounds that include silver (Ag) and an s-triazine ring with substitutions at nitrogen or carbon atoms of the s-triazine ring. In one example, the antimicrobial silver s-triazine may be readily incorporated in a variety of compositions and devices in both medical and non-medical settings. In another example, the said compounds may possess broad spectrum antimicrobial activity against bacteria, viruses, fungi and other microbes.

The present disclosure pertains to antimicrobial compounds that include silver (Ag) and an s-triazine ring with substitutions at nitrogen or carbon atoms of the s-triazine ring. In one example, the antimicrobial silver s-triazine may be readily incorporated in a variety of compositions and devices in both medical and non-medical settings. In another example, the said compounds may possess broad spectrum antimicrobial activity against bacteria, viruses, fungi and other microbes.